• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

层流的抗炎作用:过氧化物酶体增殖物激活受体γ、环氧二十碳三烯酸及可溶性环氧水解酶的作用

The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.

作者信息

Liu Yi, Zhang Yingjia, Schmelzer Kara, Lee Tzong-Shyuan, Fang Xiang, Zhu Yi, Spector Arthur A, Gill Sarjeet, Morisseau Christophe, Hammock Bruce D, Shyy John Y-J

机构信息

Division of Biomedical Sciences, University of California, Riverside, CA 92521, USA.

出版信息

Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16747-52. doi: 10.1073/pnas.0508081102. Epub 2005 Nov 2.

DOI:10.1073/pnas.0508081102
PMID:16267130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1276614/
Abstract

We previously reported that laminar flow activates peroxisome proliferator-activated receptor gamma (PPARgamma) in vascular endothelial cells in a ligand-dependent manner that involves phospholipase A2 and cytochrome P450 epoxygenases. In this study, we investigated whether epoxyeicosatrienoic acids (EETs), the catalytic products of cytochrome P450 epoxygenases, are PPARgamma ligands. Competition and direct binding assays revealed that EETs bind to the ligand-binding domain of PPARgamma with K(d) in the microM range. In the presence of adamantyl-ureido-dodecanoic acid (AUDA), a soluble epoxide hydrolase (sEH)-specific inhibitor, EETs increased PPARgamma transcription activity in endothelial cells and 3T3-L1 preadipocytes. Inclusion of AUDA in the perfusing media enhanced, but overexpression of sEH reduced, the laminar flow-induced PPARgamma activity. Furthermore, laminar flow augmented cellular levels of EETs but decreased sEH at the levels of mRNA, protein, and activity. Blocking PPARgamma by GW9662 abolished the EET/AUDA-mediated antiinflammatory effect, which indicates that PPARgamma is an effector of EETs.

摘要

我们之前报道过,层流以一种依赖配体的方式激活血管内皮细胞中的过氧化物酶体增殖物激活受体γ(PPARγ),这种方式涉及磷脂酶A2和细胞色素P450环氧合酶。在本研究中,我们调查了细胞色素P450环氧合酶的催化产物环氧二十碳三烯酸(EETs)是否为PPARγ配体。竞争和直接结合试验表明,EETs以微摩尔范围内的解离常数(K(d))与PPARγ的配体结合域结合。在存在金刚烷基脲基十二烷酸(AUDA)(一种可溶性环氧化物水解酶(sEH)特异性抑制剂)的情况下,EETs增加了内皮细胞和3T3-L1前脂肪细胞中的PPARγ转录活性。在灌注培养基中加入AUDA可增强层流诱导的PPARγ活性,但sEH的过表达则降低该活性。此外,层流增加了细胞内EETs的水平,但在mRNA、蛋白质和活性水平上降低了sEH。用GW9662阻断PPARγ消除了EET/AUDA介导的抗炎作用,这表明PPARγ是EETs的效应器。

相似文献

1
The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.层流的抗炎作用:过氧化物酶体增殖物激活受体γ、环氧二十碳三烯酸及可溶性环氧水解酶的作用
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16747-52. doi: 10.1073/pnas.0508081102. Epub 2005 Nov 2.
2
Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells.层流可激活血管内皮细胞中的过氧化物酶体增殖物激活受体γ 。
Circulation. 2004 Aug 31;110(9):1128-33. doi: 10.1161/01.CIR.0000139850.08365.EC. Epub 2004 Aug 16.
3
Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.腺苷 A2A 受体通过 CYP-环氧合酶和 PPARγ 调节可溶性环氧化物水解酶敲除小鼠的血管反应。
Am J Physiol Regul Integr Comp Physiol. 2013 Jan 1;304(1):R23-32. doi: 10.1152/ajpregu.00213.2012. Epub 2012 Nov 14.
4
17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.17,18-环氧二十碳四烯酸靶向 PPARγ 和 p38 丝裂原活化蛋白激酶来介导其在肺部的抗炎作用:可溶性环氧化物水解酶的作用。
Am J Respir Cell Mol Biol. 2010 Nov;43(5):564-75. doi: 10.1165/rcmb.2009-0155OC. Epub 2009 Dec 11.
5
A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.强效可溶型环氧化物水解酶抑制剂 t-AUCB 通过 PPARγ 调节急性心肌梗死患者内皮祖细胞的功能。
Int J Cardiol. 2013 Aug 20;167(4):1298-304. doi: 10.1016/j.ijcard.2012.03.167. Epub 2012 Apr 21.
6
Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.取代脲衍生的可溶性环氧化物水解酶抑制剂对过氧化物酶体增殖物激活受体α的激活作用。
J Pharmacol Exp Ther. 2005 Jul;314(1):260-70. doi: 10.1124/jpet.105.085605. Epub 2005 Mar 29.
7
Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.抑制可溶性环氧化物水解酶并不能预防内毒素介导的肝脏炎症。
J Pharmacol Exp Ther. 2008 Dec;327(3):707-15. doi: 10.1124/jpet.108.142398. Epub 2008 Sep 24.
8
High salt diet modulates vascular response in A2AAR (+/+) and A 2AAR (-/-) mice: role of sEH, PPARγ, and K ATP channels.高盐饮食对A2AAR(+/+)和A2AAR(-/-)小鼠血管反应的调节作用:可溶性环氧化物水解酶、过氧化物酶体增殖物激活受体γ及ATP敏感性钾通道的作用
Mol Cell Biochem. 2015 Jun;404(1-2):87-96. doi: 10.1007/s11010-015-2368-4. Epub 2015 Mar 5.
9
Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF-1-Smad2/3 Signaling in a PPAR-Dependent Manner.环氧二十碳三烯酸通过以 PPAR 依赖的方式阻断 TGF-β1-Smad2/3 信号转导抑制小鼠成纤维细胞的激活。
Oxid Med Cell Longev. 2022 Oct 13;2022:7265486. doi: 10.1155/2022/7265486. eCollection 2022.
10
Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.可溶性环氧化物水解酶的消融通过增加线粒体完整性、体外和体内的血红素加氧酶-1-脂联素,将白色脂肪重编程为米色样脂肪。
Prostaglandins Other Lipid Mediat. 2018 Sep;138:1-8. doi: 10.1016/j.prostaglandins.2018.07.004. Epub 2018 Jul 21.

引用本文的文献

1
Endothelial soluble epoxide hydrolase links polyunsaturated fatty acid metabolism to oxidative stress and atherosclerosis progression.内皮可溶性环氧化物水解酶将多不饱和脂肪酸代谢与氧化应激和动脉粥样硬化进展联系起来。
Redox Biol. 2025 Jun 14;85:103730. doi: 10.1016/j.redox.2025.103730.
2
Dynamics of Fatty Acid Composition in Lipids and Their Distinct Roles in Cardiometabolic Health.脂质中脂肪酸组成的动态变化及其在心脏代谢健康中的独特作用。
Biomolecules. 2025 May 10;15(5):696. doi: 10.3390/biom15050696.
3
Structure-Based Design and Optimization Lead to the Identification of a Novel Potent sEH Inhibitor with PPARγ Partial Agonist Activity against Inflammatory and Metabolic-Related Diseases.基于结构的设计与优化促成了一种新型强效可溶性环氧化物水解酶(sEH)抑制剂的发现,该抑制剂具有过氧化物酶体增殖物激活受体γ(PPARγ)部分激动活性,可用于治疗炎症和代谢相关疾病。
J Med Chem. 2025 Apr 24;68(8):8729-8767. doi: 10.1021/acs.jmedchem.5c00402. Epub 2025 Apr 4.
4
Dysregulation of the Arachidonic Acid Pathway in Cystic Fibrosis: Implications for Chronic Inflammation and Disease Progression.囊性纤维化中花生四烯酸途径的失调:对慢性炎症和疾病进展的影响。
Pharmaceuticals (Basel). 2024 Sep 9;17(9):1185. doi: 10.3390/ph17091185.
5
Hedan tablet ameliorated non-alcoholic steatohepatitis by moderating NF-κB and lipid metabolism-related pathways via regulating hepatic metabolites.鹤丹片通过调节肝内代谢物,调控 NF-κB 和脂质代谢相关通路改善非酒精性脂肪性肝炎。
J Cell Mol Med. 2024 Apr;28(7):e18194. doi: 10.1111/jcmm.18194.
6
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality.双重靶向 sEH 和 HDAC6 抑制剂的设计与合成及其在治疗神经病理性疼痛和脂多糖诱导的死亡率中的应用。
J Med Chem. 2024 Feb 8;67(3):2095-2117. doi: 10.1021/acs.jmedchem.3c02006. Epub 2024 Jan 18.
7
1,3-Dichloroadamantyl-Containing Ureas as Potential Triple Inhibitors of Soluble Epoxide Hydrolase, p38 MAPK and c-Raf.含 1,3-二氯金刚烷基的脲类作为潜在的可溶性环氧化物水解酶、p38MAPK 和 c-Raf 的三重抑制剂。
Int J Mol Sci. 2023 Dec 26;25(1):338. doi: 10.3390/ijms25010338.
8
Crocin Ameliorates Diabetic Nephropathy through Regulating Metabolism, CYP4A11/PPARγ, and TGF-β/Smad Pathways in Mice.藏红花酸通过调节代谢、CYP4A11/PPARγ 和 TGF-β/Smad 通路改善糖尿病肾病小鼠模型。
Curr Drug Metab. 2023;24(10):709-722. doi: 10.2174/0113892002257928231031113337.
9
Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease.酒精相关性肝病中可溶性环氧化物水解酶抑制后肝转录组及其调控
Am J Pathol. 2024 Jan;194(1):71-84. doi: 10.1016/j.ajpath.2023.09.016. Epub 2023 Nov 3.
10
Arachidonic acid metabolism in health and disease.健康与疾病中的花生四烯酸代谢
MedComm (2020). 2023 Sep 20;4(5):e363. doi: 10.1002/mco2.363. eCollection 2023 Oct.

本文引用的文献

1
Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells.层流可激活血管内皮细胞中的过氧化物酶体增殖物激活受体γ 。
Circulation. 2004 Aug 31;110(9):1128-33. doi: 10.1161/01.CIR.0000139850.08365.EC. Epub 2004 Aug 16.
2
The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS.采用高效液相色谱-串联质谱法同时定量尿液中细胞色素P450依赖性亚油酸和花生四烯酸代谢物。
J Lipid Res. 2002 Sep;43(9):1563-78. doi: 10.1194/jlr.d200018-jlr200.
3
Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells.过氧化物酶体增殖物激活受体γ的组成性激活可抑制人血管内皮细胞中的促炎粘附分子。
J Biol Chem. 2002 Sep 13;277(37):34176-81. doi: 10.1074/jbc.M203436200. Epub 2002 Jul 9.
4
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.基于尿素的可溶性环氧化物水解酶抑制剂的结构优化
Biochem Pharmacol. 2002 May 1;63(9):1599-608. doi: 10.1016/s0006-2952(02)00952-8.
5
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.可溶性环氧化物水解酶抑制可降低血管紧张素II高血压患者的动脉血压。
Hypertension. 2002 Feb;39(2 Pt 2):690-4. doi: 10.1161/hy0202.103788.
6
PPARgamma and atherosclerosis: effects on cell growth and movement.过氧化物酶体增殖物激活受体γ与动脉粥样硬化:对细胞生长和运动的影响
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1891-5. doi: 10.1161/hq1201.100261.
7
Peroxisome proliferator-activated receptors in endothelial cell biology.内皮细胞生物学中的过氧化物酶体增殖物激活受体
Curr Opin Lipidol. 2001 Oct;12(5):511-8. doi: 10.1097/00041433-200110000-00006.
8
Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.内皮细胞中环氧二十碳三烯酸的代谢途径。可溶性环氧水解酶抑制对血管的影响
J Biol Chem. 2001 May 4;276(18):14867-74. doi: 10.1074/jbc.M011761200. Epub 2001 Feb 7.
9
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.曲格列酮可抑制糖尿病和非糖尿病低密度脂蛋白受体缺陷小鼠早期动脉粥样硬化病变的形成。
Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):365-71. doi: 10.1161/01.atv.21.3.365.
10
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation.可溶性环氧化物水解酶的靶向破坏揭示了其在血压调节中的作用。
J Biol Chem. 2000 Dec 22;275(51):40504-10. doi: 10.1074/jbc.M008106200.